Clinical management and treatment outcomes of Merkel cell carcinoma

Australian and New Zealand Journal of Surgery

Volumn 68, Issue 5, 1998, Pages 354-358

  Wong, Kenneth C ^a   Zuletta, Fred ^a   Clarke, Stephen J ^a   Kennedy, Peter J ^a  

^a Department of Microbiology and Infectious Diseases   (Australia)

Author keywords

Management; Merkel cell carcinoma; Metastases; Recurrence; Survival

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; FEMALE; HUMAN; MALE; MERKEL CELL TUMOR; PROGNOSIS; SKIN CARCINOMA; SUN EXPOSURE; TREATMENT PLANNING;

EID: 0031777199     PISSN: 00048682     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-2197.1998.tb04771.x     Document Type: Article

References (35)

1. Toker C. Trabecular carcinoma of the skin. Arch. Dermatol. 1972; 105: 107-10.
2. Halata Z. Sensory innervation of hairy skin (light and electron-microscopic study). J. Invest. Dermatol. 1993; 101: 75S-81S.
3. Kim DK, Holbrook KA. The appearance, density and distribution of Merkel cells in human embryonic and fetal skin: Their relation to sweat gland and hair follicle development. J. Invest. Dermatol. 1995; 104:411-16.
4. Warner T, Uno H, Hafez G et al. Merkel cells and Merkel cell tumors: Ultrastructure, immunocytochemistry and a review of the literature. Cancer 1983; 52: 238-45.
5. Pilotti S, Rilke F, Lombardi L. Neuroendocrine (Merkel Cell) carcinoma of the skin. Am. J. Surg. Pathol. 1982; 6: 243-54.
6. Silva EG, Mackay B, Goepfert H, Burgess M, Fields RS. Endocrine carcinoma of the skin (Merkel cell carcinoma). Pathol. Ann. 1984; 19: 1-30.
7. Hitchcock CL, Bland KI, Laney RG, Franzini D, Harris B, Copeland EM. Neuroendocrine (Merkel cell) carcinoma of the skin: Its natural history, diagnosis and treatment. Ann. Surg. 1988; 207: 201-7.
8. Bourne RG, O'Rouke MGE. Management of Merkel cell tumour. Aust. N.Z. J. Surg. 1988; 58: 971-4.
9. Marks ME, Kim RY, Salter MM. Radiotherapy as an adjuvant in the management of Merkel cell carcinoma. Cancer 1990; 65: 60-4.
10. Sibley RK, Dehner LP, Rosai J. Primary neuroendocrine (Merkel cell?) carcinoma of the skin: A clinicopathological and ultrastructural study of 43 cases. Am. J. Surg. Pathol. 1985; 9: 95-108.
11. Wick MR, Goellner JR, Scheithauer BW et al. Primary neuroendocrine carcinomas of the skin (Merkel cell tumors): A clinical, histologic and ultrastructural study of 13 cases. Am. J. Clin. Pathol. 1983; 79: 6-13.
12. Meland NB, Jackson IT. Merkel cell tumour: Diagnosis, prognosis and management. Plast. Reconstr. Surg. 1986; 77: 632-7.
13. Shaw JHF, Rumball E, Merkel cell tumour: Clinical behaviour and treatment. Br. J. Surg. 1991; 78: 138-42.
14. Raaf JH, Urmacher C, Knapper WK, Shiu MH, Cheng EWK. Trabecular (Merkel cell) carcinoma of the skin. Cancer 1986: 57: 178-82.
15. Szadowska A, Wozmak L, Lasota J, Mirecka B, Wolska H. Neuroendocrine (Merkel cell) carcinoma of the skin: A clinicomorphological study of 13 cases. Histopathology 1989; 15: 483-93.
16. Yiengpruksawan A, Coit DG, Thaler HT, Urmacher C, Knapper WK. Merkel cell carcinoma: Prognosis and management. Arch. Surg. 1991; 26: 1514-19.
17. Al Ghazal SK, Arora DS, Simpson RHW, Saxby P. Merkel cell carcinoma of the skin. Br. J. Plast. Surg. 1996; 49: 491-6.
18. Merot Y, Margolis RJ, Dahl D, Saurai J-H. Mihm MC Jr. Coexpression of neurofilament and keratin proteins in cutaneous neuroendocrine carcinoma cells. J. Invest. Dermatol. 1986; 86: 74-7.
19. Collar AM, Gates JO, Gibbs FA. Merkel cell carcinoma: Combined surgery and radiation therapy. Am. Surg. 1986; 52: 159-64.
20. Pacella J, Ashby M. Ainslie J, Minty C. The role of radiotherapy in the management of primary cutaneous neuroendocrine tumors (Merkel cell or trabecular carcinoma): Experience at the Peter MacCallum Institute (Melbourne, Australia). Int. J. Radiat. Oncol. Biol. Phys. 1988; 14: 1077-84.
21. Ashby MA, Jones DH, Tasker AD, Blackshaw AJ. Primary cutaneous neuroendocrine (Merkel cell or trabecular carcinoma) tumor of the skin: A radioresponsive tumor. Clin. Radiol. 1989; 40: 85-7.
22. Wilder RB, Harari PM, Graham AR, Shimm DS, Cassady JR. Merkel cell carcinoma. Improved locoregional control with postoperative radiation therapy. Cancer 1991; 68: 1004-8.
23. Morrison WH, Peters LJ, Silva EG, Wendt CD, Ang KK, Goepfert H. The essential role of radiation therapy in securing locoregional control of Merkel cell carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 1990; 19: 583-91.
24. O'Brien PC, Denham JW, Leong AS-Y. Merkel cell carcinoma: A review of behaviour patterns and mangement strategies. Aust. N.Z. J. Surg. 1987; 57: 847-50.
25. Meeuwissen JA, Bourne RG, Kearsley JH. The importance of postoperative radiation therapy in the treatment of Merkel cell carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 1995; 31: 325-31.
26. George TK, Di Sant' Agnese PA, Bennett JM. Chemotherapy for metastatic Merkel cell carcinoma. Cancer 1985; 56: 1034-8.
27. Feun LG, Savaraji N, Legha S, Silva EG, Benjamin RS, Burgess MA. Chemotherapy for metastatic Merkel cell carcinoma: Review of the MD. Anderson Hospital's Experience. Cancer 1988; 62: 683-5.
28. Wynne CJ, Kearsley JH. Merkel cell tumor: A chemosensitive skin cancer. Cancer 1988; 62: 28-31.
29. Boyle V, Pendlehury S, Bell D. Further insights into the natural history and management of primary cutaneous neuroendocrine (Merkel cell) carcinoma. Int. J. Radial. Oncol. Biol. Phys. 1995; 31: 315-23.
30. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 1958; 53: 457-81.
31. Gomez LG, DiMaio S, Silva EG, MacKay B. Association between neuroendocrine (Merkel cell) carcinoma and squamous carcinoma of the skin. Am. J. Surg. Pathol. 1983; 7: 171-7.
32. Bielamowicz. S, Smith D, Abemayor E. Merkel cell carcinoma: An aggressive skin neoplasm. Laryngoscope 1994; 104: 528-32.
33. Raghavan D, Findlay MPN, McNeil EB. Cancer in the elderly. In: Peckam M et ai (eds). Oxford Textbook of Oncology, vol. 2. Oxford University Press, 1995; 2169-89.
34. Egorin MJ, Van Echo DA, Tipping SJ et al. Pharniacokinetics and dosage reduction of cis-diammine (1, 1-cyclobutanedicarboxylato) platinum in patients with impaired renal function. Cancer Res. 1984; 44: 5432-8.
35. Egorin MJ, Van Echo DA, Olman EA, Whitacre MY, Forrest A, Aisner J. Prospective validation of a pharmacologically based dosing scheme for the cis-diamminedichloro platinum (II) analogue diamminecyclobutane-dicarboxylatoplatinum. Cancer Res. 1985; 45: 6502-6.